These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3370074)

  • 21. Biotransformation of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, in mice, rats, rabbits, dogs, monkeys, and chimpanzees.
    Riska PS; Joseph DP; Dinallo RM; Davidson WC; Keirns JJ; Hattox SE
    Drug Metab Dispos; 1999 Dec; 27(12):1434-47. PubMed ID: 10570025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The disposition of bornaprine hydrochloride in the rat. 2. The metabolism of exo-epimers].
    Neidlein R; Pichler B; Hege G; Weymann J
    Arzneimittelforschung; 1989 May; 39(5):564-9. PubMed ID: 2757672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of di-n-butylphthalate biotransformation in cattle by liquid chromatography/ion trap mass spectrometry/mass spectrometry.
    Coldham NG; Dave M; Sauer MJ
    J Mass Spectrom; 1998 Sep; 33(9):803-10. PubMed ID: 9768498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Biotransformation and pharmacokinetics of mesionic didehydro-4-methyl-5-phenyl-1,3,4-thiadiazolidine-2-thione (LU 2443). Studies on the pharmacokinetics in rats].
    Neidlein R; Eder T
    Arzneimittelforschung; 1982; 32(11):1447-52. PubMed ID: 6891252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans.
    Dow J; Piriou F; Wolf E; Dulery BD; Haegele KD
    Drug Metab Dispos; 1994; 22(5):738-49. PubMed ID: 7835226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutagenic metabolites in urine and feces of rats fed with 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline, a carcinogenic mutagen present in cooked meat.
    Hayatsu H; Kasai H; Yokoyama S; Miyazawa T; Yamaizumi Z; Sato S; Nishimura S; Arimoto S; Hayatsu T; Ohara Y
    Cancer Res; 1987 Feb; 47(3):791-4. PubMed ID: 3542193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans.
    Weinz C; Schwarz T; Kubitza D; Mueck W; Lang D
    Drug Metab Dispos; 2009 May; 37(5):1056-64. PubMed ID: 19196845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Biotransformation of alimemazine].
    Pfeifer S; Bornschein I; Franke P; Fischer C
    Pharmazie; 1986 Feb; 41(2):111-3. PubMed ID: 3725848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism of carbamazepine.
    Lertratanangkoon K; Horning MG
    Drug Metab Dispos; 1982; 10(1):1-10. PubMed ID: 6124375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Biotransformation of 5-phenyl-1,3,4-benzotriazepines].
    Pfeifer S; Niepel C; Franke P
    Pharmazie; 1989 Jan; 44(1):51-5. PubMed ID: 2727031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biotransformation of the stable prostacyclin analogue, iloprost, in the rat.
    Krause W; Hümpel M; Hoyer GA
    Drug Metab Dispos; 1984; 12(5):645-51. PubMed ID: 6209077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo and in vitro metabolism of lefucoxib in rats.
    Bi X; Meng Z; Chen H; Zhu X; Dou G
    J Pharm Biomed Anal; 2008 Sep; 48(1):134-9. PubMed ID: 18538525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of efonidipine hydrochloride metabolites in rats.
    Nakabeppu H; Nakajima A; Kamikawaji Y; Shinozaki Y
    Arzneimittelforschung; 1995 Jul; 45(7):766-70. PubMed ID: 8573219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Excretion and biotransformation of ketanserin after oral and intravenous administration in rats and dogs.
    Meuldermans W; Hendrickx J; Lauwers W; Swysen E; Hurkmans R; Knaeps F; Woestenborghs R; Heykants J
    Drug Metab Dispos; 1984; 12(6):772-81. PubMed ID: 6150829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The metabolic fate of supidimide in the rat.
    Becker R; Frankus E; Graudums I; Günzler WA; Helm FC; Flohé L
    Arzneimittelforschung; 1982; 32(9):1101-11. PubMed ID: 6890834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxicokinetics and biotransformation of 3-(4-methylbenzylidene)camphor in rats after oral administration.
    Völkel W; Colnot T; Schauer UM; Broschard TH; Dekant W
    Toxicol Appl Pharmacol; 2006 Oct; 216(2):331-8. PubMed ID: 16806338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolism of dimetindene in rats.
    Radler S; Wermeille M; Blaschke G
    Arzneimittelforschung; 1995 Oct; 45(10):1086-92. PubMed ID: 8595065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Metabolic products of methandrostenolone in the body of white rats studied by high-performance liquid chromatography].
    Krylov IuF; Krynetskiĭ EIu; Prokhorov BS; Sapozhnikova GA; Smirnov PA
    Farmakol Toksikol; 1988; 51(2):74-8. PubMed ID: 3378611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of rat faecal metabolites of ebastine by B/E linked scanning liquid secondary ion mass spectrometry.
    Yoshida K; Hatoyama T; Fujii T; Kagemoto A; Miyazaki H; Naruto S
    Biol Mass Spectrom; 1994 Jul; 23(7):385-90. PubMed ID: 7915143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.